PMAM
DNTH icon

Penn Mutual Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Penn Mutual Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-572
Closed -$89K – 74
2021
Q2 		$89K Buy
+572
New +$105K 0.11% 85
2019
Q2 		– Sell
-1,619
Closed -$26K – 23
2019
Q1 		$26K Buy
+1,619
New +$279K 0.3% 17

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Penn Mutual Asset Management's DNTH Position: Q3 2021 in Review

Penn Mutual Asset Management sold out of Dianthus Therapeutics (DNTH) in Q3 2021, closing a stake of 572 shares — an estimated $89K sold.

Penn Mutual Asset Management first reported a position in DNTH in Q1 2019 and held it in 2 quarters. The position peaked at $89K in Q2 2021. 93 funds tracked by Wall St. Rank hold DNTH as of Q3 2021.

  • Penn Mutual Asset Management reported no remaining Dianthus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Penn Mutual Asset Management sold 572 Dianthus Therapeutics shares in Q3 2021, an estimated $89K.
  • Penn Mutual Asset Management first reported a position in Dianthus Therapeutics in Q1 2019 and held it in 2 quarters.
  • Penn Mutual Asset Management's Dianthus Therapeutics position peaked at $89K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2021.

Based on Penn Mutual Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.